• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3622252
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
33.77
116228.74
EPS(TTM)
Face Value()
Div & Yield %
42.61
2
0.9
 

radhagobind commercial ltd
Raghuvir Synthetics reports consolidated net loss of Rs 3.58 crore in the March 2026 quarter
May 29,2026
Net loss of Raghuvir Synthetics reported to Rs 3.58 crore in the quarter ended March 2026 as against net profit of Rs 4.11 crore during the previous quarter ended March 2025. Sales declined 73.14% to Rs 24.18 crore in the quarter ended March 2026 as against Rs 90.01 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.28 crore in the year ended March 2026 as against net profit of Rs 9.03 crore during the previous year ended March 2025. Sales declined 23.27% to Rs 255.19 crore in the year ended March 2026 as against Rs 332.57 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales24.1890.01 -73 255.19332.57 -23
OPM %-5.256.55 -3.124.91 -
PBDT-1.816.00 PL 6.9817.44 -60
PBT-3.473.93 PL -1.198.72 PL
NP-3.584.11 PL -1.289.03 PL